Evidence map›Paper›PMID 30440048›Full record

ArticlePloS one2018

Impact of meropenem on Klebsiella pneumoniae metabolism.

Claudio Foschi, Melissa Salvo, Luca Laghi, Chenglin Zhu, Simone Ambretti, Antonella Marangoni, Maria Carla Re

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. LC-MS/MS metabolomics unravels the resistant phenotype of carbapenemase-producing Enterobacterales.Metabolomics : Official journal of the Metabolomic Society · 2025
    Article
  3. Article
  4. Metabolic response of Klebsiella oxytoca to ciprofloxacin exposure: a metabolomics approach.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  5. Article
  6. Detection of blaBMC microbiology · 2024
    Article
  7. Article
  8. Sample Preparation in Microbial Metabolomics: Advances and Challenges.Advances in experimental medicine and biology · 2023
    Article
  9. Review
  10. Article
  11. First-Void Urine Microbiome in Women withInternational journal of molecular sciences · 2022
    Article
  12. Inosine and D-Mannose Secreted by Drug-ResistantMolecules (Basel, Switzerland) · 2022
    Article
  13. GC-MS profiling of volatile metabolites produced byFrontiers in molecular biosciences · 2022
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Claudio FoschiMicrobiology, DIMES, University of Bologna, Bologna, Italy.ORCID 0000-0001-7253-8799
Melissa SalvoMicrobiology, DIMES, University of Bologna, Bologna, Italy.
Luca LaghiCentre of Foodomics, Department of Agro-Food Science and Technology, University of Bologna, P.za Goidanich, Cesena, Italy.
Chenglin ZhuCentre of Foodomics, Department of Agro-Food Science and Technology, University of Bologna, P.za Goidanich, Cesena, Italy.ORCID 0000-0003-3486-1936
Simone AmbrettiMicrobiology Unit, S.Orsola-Malpighi Hospital, Bologna, Italy.
Antonella MarangoniMicrobiology, DIMES, University of Bologna, Bologna, Italy.
Maria Carla ReMicrobiology, DIMES, University of Bologna, Bologna, Italy.
University of Bologna · ITIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to analyze the metabolome of several Klebsiella pneumoniae strains characterized by different resistance patterns. A total of 59 bacterial strains (27 carbapenemase-negative and 32 carbapenemase-positive) were included and their metabolic features were assessed in basal conditions. Moreover, 8 isolates (4 wild-type and 4 KPC-producers) were randomly selected to evaluate the impact of sub-lethal concentrations of meropenem on bacterial metabolism. The metabolomic analysis was performed by 1H-NMR spectroscopy both on filtered supernatants and cell lysates. A total of 40 and 20 molecules were quantified in the intracellular and the extracellular metabolome, respectively. While in basal conditions only five metabolites showed significant differences between carbapenemase-positive and negative strains, the use of meropenem had a profound impact on the whole bacterial metabolism. In the intracellular compartment, a reduction of different overflow metabolites and organic acids (e.g. formate, acetate, isobutyrate) was noticed, whereas, in the extracellular metabolome, the levels of several organic acids (e.g. succinate, acetate, formate, lactate) and amino acids (aspartate, threonine, lysine, alanine) were modified by meropenem stimulation. Interestingly, carbapenemase-positive and negative strains reacted differently to meropenem in terms of number and type of perturbed metabolites. In wild-type strains, meropenem had great impact on the metabolic pathways related to methane metabolism and alanine, aspartate and glutamate metabolism, whereas in KPC-producers the effect was predominant on pyruvate metabolism. The knowledge about the bacterial metabolic profiles could help to set up innovative diagnostic methods and new antimicrobial strategies to fight the global crisis against carbapenemase-positive K. pneumoniae.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesHumansKlebsiella InfectionsKlebsiella pneumoniaeMeropenemMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseMeropenem

Identifiers

PMID30440048
PMCPMC6237392
OpenAlexW2901863390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.